ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke ® ECAP-Controlled, ...
Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop ...
Evoke is a novel, closed-loop SCS system that instantaneously reads, records, and responds to evoked compound action potentials. The Food and Drug Administration (FDA) has approved the Evoke ® Spinal ...
The data comprised results from a pair of studies tracking the results of two of Medtronic’s newest approaches to spinal cord stimulation: its Inceptiv closed-loop system and the differential target ...
Spinal cord stimulation (SCS) therapies for chronic back and/or leg pain is superior to conventional medical management (CMM) for reduced pain intensity and functional disability, new research ...
Medtronic plc is looking to increase market share in pain stimulation with its differential target multiplexed (DTM) therapy, a recharge-free device and its next big disrupter, evoked compound action ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results